Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 153

Similar articles for PubMed (Select 19419302)

1.

PGE2 signaling through the EP4 receptor on fibroblasts upregulates RANKL and stimulates osteolysis.

Tsutsumi R, Xie C, Wei X, Zhang M, Zhang X, Flick LM, Schwarz EM, O'Keefe RJ.

J Bone Miner Res. 2009 Oct;24(10):1753-62. doi: 10.1359/jbmr.090412.

2.

Fibroblasts express RANKL and support osteoclastogenesis in a COX-2-dependent manner after stimulation with titanium particles.

Wei X, Zhang X, Zuscik MJ, Drissi MH, Schwarz EM, O'Keefe RJ.

J Bone Miner Res. 2005 Jul;20(7):1136-48. Epub 2005 Feb 14.

PMID:
15940366
3.
4.

SC-19220, antagonist of prostaglandin E2 receptor EP1, inhibits osteoclastogenesis by RANKL.

Tsujisawa T, Inoue H, Nishihara T.

J Bone Miner Res. 2005 Jan;20(1):15-22. Epub 2004 Oct 18.

PMID:
15619665
5.

Downregulation of lipopolysaccharide-induced intercellular adhesion molecule-1 expression via EP2/EP4 receptors by prostaglandin E2 in human fibroblasts.

Noguchi K, Iwasaki K, Shitashige M, Umeda M, Izumi Y, Murota S, Ishikawa I.

Inflammation. 2001 Apr;25(2):75-81.

PMID:
11321362
6.
7.

Regulatory effects of interleukin-1beta and prostaglandin E2 on expression of receptor activator of nuclear factor-kappaB ligand in human periodontal ligament cells.

Nukaga J, Kobayashi M, Shinki T, Song H, Takada T, Takiguchi T, Kamijo R, Hasegawa K.

J Periodontol. 2004 Feb;75(2):249-59.

PMID:
15068113
8.

Characterization and regulation of prostaglandin E2 receptor and receptor-coupled functions in the choroidal vasculature of the pig during development.

Abran D, Dumont I, Hardy P, Peri K, Li DY, Molotchnikoff S, Varma DR, Chemtob S.

Circ Res. 1997 Apr;80(4):463-72.

PMID:
9118476
9.

Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.

Nüsing RM, Treude A, Weissenberger C, Jensen B, Bek M, Wagner C, Narumiya S, Seyberth HW.

J Am Soc Nephrol. 2005 Aug;16(8):2354-62. Epub 2005 Jun 23.

11.

Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling.

Boniface K, Bak-Jensen KS, Li Y, Blumenschein WM, McGeachy MJ, McClanahan TK, McKenzie BS, Kastelein RA, Cua DJ, de Waal Malefyt R.

J Exp Med. 2009 Mar 16;206(3):535-48. doi: 10.1084/jem.20082293. Epub 2009 Mar 9.

12.

The cyclooxygenase-2-prostaglandin E2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts.

Dagouassat M, Gagliolo JM, Chrusciel S, Bourin MC, Duprez C, Caramelle P, Boyer L, Hue S, Stern JB, Validire P, Longrois D, Norel X, Dubois-Randé JL, Le Gouvello S, Adnot S, Boczkowski J.

Am J Respir Crit Care Med. 2013 Apr 1;187(7):703-14. doi: 10.1164/rccm.201208-1361OC.

PMID:
23328527
13.

Prostaglandin receptor EP2 mediates PGE2 stimulated hypercalcemia in mice in vivo.

Li X, Tomita M, Pilbeam CC, Breyer RM, Raisz LG.

Prostaglandins Other Lipid Mediat. 2002 Apr;67(3-4):173-80.

PMID:
12013525
14.

Prostaglandin E₂ inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors.

Li YJ, Wang XQ, Sato T, Kanaji N, Nakanishi M, Kim M, Michalski J, Nelson AJ, Sun JH, Farid M, Basma H, Patil A, Toews ML, Liu X, Rennard SI.

Am J Respir Cell Mol Biol. 2011 Jan;44(1):99-107. doi: 10.1165/rcmb.2009-0163OC. Epub 2010 Mar 4.

15.

Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.

Timoshenko AV, Xu G, Chakrabarti S, Lala PK, Chakraborty C.

Exp Cell Res. 2003 Oct 1;289(2):265-74.

PMID:
14499627
16.

Inhibitory effect of prostaglandin E(2) on the migration of nasal fibroblasts.

Shin JM, Park IH, Moon YM, Hong SM, Cho JS, Um JY, Lee HM.

Am J Rhinol Allergy. 2014 May-Jun;28(3):e120-4. doi: 10.2500/ajra.2014.28.4039.

PMID:
24980222
17.

Molecular cloning and functional characterization of the canine prostaglandin E2 receptor EP4 subtype.

Castleberry TA, Lu B, Smock SL, Owen TA.

Prostaglandins Other Lipid Mediat. 2001 Jul;65(4):167-87.

PMID:
11444589
18.
19.

Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype.

Foudi N, Kotelevets L, Louedec L, Leséche G, Henin D, Chastre E, Norel X.

Br J Pharmacol. 2008 Aug;154(8):1631-9. doi: 10.1038/bjp.2008.214. Epub 2008 Jun 2.

20.

Soluble EP2 neutralizes prostaglandin E2-induced cell signaling and inhibits osteolytic tumor growth.

Takahashi T, Uehara H, Bando Y, Izumi K.

Mol Cancer Ther. 2008 Sep;7(9):2807-16. doi: 10.1158/1535-7163.MCT-08-0153.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk